Immunosenescence in monocytes, macrophages, and dendritic cells: Lessons learned from the lung and heart

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 290-297

  Linton, Phyllis Jean ^a   Thoman, Marilyn L ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Aging; Dendritic cell; Heart; Lung; Macrophage; Monocytes

Indexed keywords

ANIMAL; CARDIAC MUSCLE; CELL AGING; DENDRITIC CELL; GENETICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOLOGY; LUNG; MACROPHAGE; METABOLISM; MONOCYTE; PATHOLOGY; PHAGOCYTE;

ANIMALS; CELL AGING; DENDRITIC CELLS; HUMANS; LUNG; MACROPHAGES; MONOCYTES; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHAGOCYTES;

EID: 84914100710     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.06.017     Document Type: Article

References (149)

1. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000, 908:244-254.
2. Adamson R. Role of macrophages in normal wound healing: an overview. J Wound Care 2009, 18:349-351.
3. Gordon S. The macrophage: past, present and future. Eur J Immunol 2007, 37(Suppl 1):S9-S17.
4. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
5. Gordon S. Alternative activation of macrophages. Nat Rev 2003, 3:23-35.
6. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005, 175:342-349.
7. Murray P.J., Wynn T.A. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 2011, 89:557-563.
8. Nair M.G., Du Y., Perrigoue J.G., Zaph C., Taylor J.J., Goldschmidt M., et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med 2009, 206:937-952.
9. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
10. Dace D.S., Apte R.S. Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res 2008, 11:177-185.
11. Jackaman C., Radley-Crabb H.G., Soffe Z., Shavlakadze T., Grounds M.D., Nelson D.J. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice. Aging Cell 2013, 12:345-357.
12. Mahbub S., Deburghgraeve C.R., Kovacs E.J. Advanced age impairs macrophage polarization. J Interferon Cytokine Res 2012, 32:18-26.
13. Pelegrin P., Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 2009, 28:2114-2127.
14. Bruunsgaard H., Andersen-Ranberg K., Hjelmborg J., Pedersen B.K., Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 2003, 115:278-283.
15. Bruunsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003, 23:15-39.
16. Chen W., Frangogiannis N.G. The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev 2011, 15:415-422.
17. Gabay C., Lamacchia C., Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev 2010, 6:232-241.
18. Gomez C.R., Karavitis J., Palmer J.L., Faunce D.E., Ramirez L., Nomellini V., et al. Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm 2010, 2010:475139.
19. Nomellini V., Gomez C.R., Kovacs E.J. Aging and impairment of innate immunity. Contrib Microbiol 2008, 15:188-205.
20. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (New York, NY) 2006, 311:83-87.
21. Epelman S., Lavine K.J., Beaudin A.E., Sojka D.K., Carrero J.A., Calderon B., et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014, 40:91-104.
22. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (New York, NY) 2010, 330:841-845.
23. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (New York, NY) 2012, 336:86-90.
24. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
25. Kadl A., Meher A.K., Sharma P.R., Lee M.Y., Doran A.C., Johnstone S.R., et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 2010, 107:737-746.
26. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012, 122:787-795.
27. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
28. Landsman L., Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol 2007, 179:3488-3494.
29. Lambrecht B.N., Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009, 31:412-424.
30. Hashimoto D., Miller J., Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011, 35:323-335.
31. Guth A.M., Janssen W.J., Bosio C.M., Crouch E.C., Henson P.M., Dow S.W. Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol 2009, 296:L936-L946.
32. Misharin A.V., Morales-Nebreda L., Mutlu G.M., Budinger G.R., Perlman H. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am J Respir Cell Mol Biol 2013, 49:503-510.
33. Balhara J., Gounni A.S. The alveolar macrophages in asthma: a double-edged sword. Mucosal Immunol 2012, 5:605-609.
34. Beck-Schimmer B., Schwendener R., Pasch T., Reyes L., Booy C., Schimmer R.C. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res 2005, 6:61.
35. Lee J.S. Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease. J Innate Immun 2012, 4:489-497.
36. Chen B.D., Mueller M., Chou T.H. Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation. J Immunol 1988, 141:139-144.
37. Janssen W.J., Barthel L., Muldrow A., Oberley-Deegan R.E., Kearns M.T., Jakubzick C., et al. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med 2011, 184:547-560.
38. Blusse van Oud Alblas A., Mattie H., van Furth R. A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet 1983, 16:211-219.
39. Maus U.A., Janzen S., Wall G., Srivastava M., Blackwell T.S., Christman J.W., et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 2006, 35:227-235.
40. Landsman L., Varol C., Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol 2007, 178:2000-2007.
41. Dhaliwal K., Scholefield E., Ferenbach D., Gibbons M., Duffin R., Dorward D.A., et al. Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury. Am J Respir Crit Care Med 2012, 186:514-524.
42. Maus U.A., Waelsch K., Kuziel W.A., Delbeck T., Mack M., Blackwell T.S., et al. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol 2003, 170:3273-3278.
43. Guilliams M., Lambrecht B.N., Hammad H. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol 2013, 6:464-473.
44. Lin K.L., Suzuki Y., Nakano H., Ramsburg E., Gunn M.D. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008, 180:2562-2572.
45. Grayson M.H. Lung dendritic cells and the inflammatory response. Ann Allergy Asthma Immunol 2006, 96:643-651. quiz 652-3, 678.
46. Bedoret D., Wallemacq H., Marichal T., Desmet C., Quesada Calvo F., Henry E., et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest 2009, 119:3723-3738.
47. GeurtsvanKessel C.H., Willart M.A., van Rijt L.S., Muskens F., Kool M., Baas C., et al. Clearance of influenza virus from the lung depends on migratory langerin+ CD11b- but not plasmacytoid dendritic cells. J Exp Med 2008, 205:1621-1634.
48. Kim T.S., Braciale T.J. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 2009, 4:e4204.
49. Sung S.S., Fu S.M., Rose C.E., Gaskin F., Ju S.T., Beaty S.R. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006, 176:2161-2172.
50. Kawai T., Akira S. TLR signaling. Cell Death Differ 2006, 13:816-825.
51. Kong K.F., Delroux K., Wang X., Qian F., Arjona A., Malawista S.E., et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 2008, 82:7613-7623.
52. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000, 165:5392-5396.
53. Agrawal A., Gupta S. Impact of aging on dendritic cell functions in humans. Ageing Res Rev 2011, 10:336-345.
54. Ciaramella A., Spalletta G., Bizzoni F., Salani F., Caltagirone C., Bossu P. Effect of age on surface molecules and cytokine expression in human dendritic cells. Cell Immunol 2011, 269:82-89.
55. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333.
56. Wong C., Goldstein D.R. Impact of aging on antigen presentation cell function of dendritic cells. Curr Opin Immunol 2013, 25:535-541.
57. Murciano C., Yanez A., O'Connor J.E., Gozalbo D., Gil M.L. Influence of aging on murine neutrophil and macrophage function against Candida albicans. FEMS Immunol Med Microbiol 2008, 53:214-221.
58. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002, 169:4697-4701.
59. Boehmer E.D., Goral J., Faunce D.E., Kovacs E.J. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol 2004, 75:342-349.
60. Boehmer E.D., Meehan M.J., Cutro B.T., Kovacs E.J. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev 2005, 126:1305-1313.
61. Liang S., Domon H., Hosur K.B., Wang M., Hajishengallis G. Age-related alterations in innate immune receptor expression and ability of macrophages to respond to pathogen challenge in vitro. Mech Ageing Dev 2009, 130:538-546.
62. Agrawal S., Gollapudi S., Gupta S., Agrawal A. Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to lithium chloride. Exp Gerontol 2013, 48:1285-1292.
63. Lowery E.M., Brubaker A.L., Kuhlmann E., Kovacs E.J. The aging lung. Clin Interv. Aging 2013, 8:1489-1496.
64. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010, 184:2518-2527.
65. Paula C., Motta A., Schmitz C., Nunes C.P., Souza A.P., Bonorino C. Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design. Biogerontology 2009, 10:13-25.
66. Li Z., Li J., Bu X., Liu X., Tankersley C.G., Wang C., et al. Age-induced augmentation of p38 MAPK phosphorylation in mouse lung. Exp Gerontol 2011, 46:694-702.
67. Meyer K.C., Rosenthal N.S., Soergel P., Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998, 104:169-181.
68. Aoshiba K., Nagai A. Chronic lung inflammation in aging mice. FEBS Lett 2007, 581:3512-3516.
69. Shaw A.C., Panda A., Joshi S.R., Qian F., Allore H.G., Montgomery R.R. Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev 2011, 10:346-353.
70. Boyd A.R., Shivshankar P., Jiang S., Berton M.T., Orihuela C.J. Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. Exp Gerontol 2012, 47:507-518.
71. Fallah M.P., Chelvarajan R.L., Garvy B.A., Bondada S. Role of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptors. Mech Ageing Dev 2011, 132:274-286.
72. Hajishengallis G. Too old to fight? Aging and its toll on innate immunity. Mol oral microbiol 2010, 25:25-37.
73. Mares C.A., Ojeda S.S., Li Q., Morris E.G., Coalson J.J., Teale J.M. Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections. Exp Gerontol 2010, 45:91-96.
74. Qian F., Wang X., Zhang L., Lin A., Zhao H., Fikrig E., et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 2011, 203:1415-1424.
75. Toapanta F.R., Ross T.M. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res 2009, 10:112.
76. Wen J., Li C.M., Gu L., Yin S.J., Li W., Yang R. Aging reduces the expression of lung CINC and MCP-1 mRNA in a P. aeruginosa rat model of infection. Inflammation 2014, 37:933-941.
77. Wong C.P., Magnusson K.R., Ho E. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp Gerontol 2010, 45:163-169.
78. Prakash S., Agrawal S., Cao J.N., Gupta S., Agrawal A. Impaired secretion of interferons by dendritic cells from aged subjects to influenza: role of histone modifications. Age (Dordrecht, Netherlands) 2013, 35:1785-1797.
79. Stout-Delgado H.W., Vaughan S.E., Shirali A.C., Jaramillo R.J., Harrod K.S. Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J Immunol 2012, 188:2815-2824.
80. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 2009, 31:24-31.
81. Lin Y.C., Kuo H.C., Wang J.S., Lin W.W. Regulation of inflammatory response by 3-methyladenine involves the coordinative actions on Akt and glycogen synthase kinase 3beta rather than autophagy. J Immunol 2012, 189:4154-4164.
82. Wang H., Brown J., Martin M. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 2011, 53:130-140.
83. Wang H., Kumar A., Lamont R.J., Scott D.A. GSK3beta and the control of infectious bacterial diseases. Trends Microbiol 2014, 22:208-217.
84. Zhou J., Force T. Focusing the spotlight on GSK-3 in aging. Aging 2013, 5:388-389.
85. Zhou J., Freeman T.A., Ahmad F., Shang X., Mangano E., Gao E., et al. GSK-3alpha is a central regulator of age-related pathologies in mice. J Clin Invest 2013, 123:1821-1832.
86. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004, 29:95-102.
87. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 2007, 32:577-595.
88. Patel S., Woodgett J. Glycogen synthase kinase-3 and cancer: good cop, bad cop. Cancer Cell 2008, 14:351-353.
89. Kim Y.M., Song I., Seo Y.H., Yoon G. Glycogen synthase kinase 3 inactivation induces cell senescence through sterol regulatory element binding protein 1-mediated lipogenesis in Chang cells. Endocrinol Metab (Seoul, Korea) 2013, 28:297-308.
90. Okkenhaug K., Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev 2003, 3:317-330.
91. Nandan D., Camargo de Oliveira C., Moeenrezakhanlou A., Lopez M., Silverman J.M., Subek J., et al. Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3beta downstream of phosphatidylinositol-3 kinase. J Immunol 2012, 188:367-378.
92. Xu Y.P., Qi R.Q., Chen W., Shi Y., Cui Z.Z., Gao X.H., et al. Aging affects epidermal Langerhans cell development and function and alters their miRNA gene expression profile. Aging 2012, 4:742-754.
93. Williams A.E., Perry M.M., Moschos S.A., Lindsay M.A. microRNA expression in the aging mouse lung. BMC Genomics 2007, 8:172.
94. Jiang M., Xiang Y., Wang D., Gao J., Liu D., Liu Y., et al. Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell 2012, 11:29-40.
95. Barja G., Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J 2000, 14:312-318.
96. Dufour E., Boulay J., Rincheval V., Sainsard-Chanet A. A causal link between respiration and senescence in Podospora anserina. Proc Natl Acad Sci US.A 2000, 97:4138-4143.
97. Cathcart M.K. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:23-28.
98. Park J.B. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med 2003, 35:325-335.
99. Alexeyev M.F. Is there more to aging than mitochondrial DNA and reactive oxygen species. FEBS J 2009, 276:5768-5787.
100. Broadley S.A., Hartl F.U. Mitochondrial stress signaling: a pathway unfolds. Trends Cell Biol 2008, 18:1-4.
101. Durieux J., Wolff S., Dillin A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 2011, 144:79-91.
102. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009, 46:531-542.
103. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 2010, 35:505-513.
104. Roberts C.K., Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci 2009, 84:705-712.
105. Wellen K.E., Thompson C.B. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell 2010, 40:323-332.
106. Cuervo A.M. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab: TEM 2010, 21:142-150.
107. Dunlop R.A., Brunk U.T., Rodgers K.J. Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB Life 2009, 61:522-527.
108. Tyedmers J., Mogk A., Bukau B. Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 2010, 11:777-788.
109. de la Fuente M., Hernanz A., Guayerbas N., Alvarez P., Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence. Cell Mol Biol (Noisy-le-Grand, France) 2004, 50. (Online Pub: OL683-690).
110. Fujimoto H., Kobayashi H., Ohno M. Age-induced reduction in mitochondrial manganese superoxide dismutase activity and tolerance of macrophages against apoptosis induced by oxidized low density lipoprotein. Circ J 2010, 74:353-360.
111. Ponnappan S., Ovaa H., Ponnappan U. Lower expression of catalytic and structural subunits of the proteasome contributes to decreased proteolysis in peripheral blood T lymphocytes during aging. Int J Biochem Cell Biol 2007, 39:799-809.
112. Cannizzo E.S., Clement C.C., Morozova K., Valdor R., Kaushik S., Almeida L.N., et al. Age-related oxidative stress compromises endosomal proteostasis. Cell Rep 2012, 2:136-149.
113. Freund A., Orjalo A.V., Desprez P.Y., Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010, 16:238-246.
114. Salminen A., Kauppinen A., Kaarniranta K. Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal 2012, 24:835-845.
115. Sikora E., Arendt T., Bennett M., Narita M. Impact of cellular senescence signature on ageing research. Ageing Res Rev 2011, 10:146-152.
116. Chilosi M, Carloni A, Rossi A, Poletti V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl Res;162:156-73.
117. Shivshankar P., Boyd A.R., Le Saux C.J., Yeh I.T., Orihuela C.J. Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell 2011, 10:798-806.
118. Boyd A.R., Orihuela C.J. Dysregulated inflammation as a risk factor for pneumonia in the elderly. Aging Dis 2012, 2:487-500.
119. Hinojosa C.A., Akula Suresh Babu R., Rahman M.M., Fernandes G., Boyd A.R., Orihuela C.J. Elevated A20 contributes to age-dependent macrophage dysfunction in the lungs. Exp Gerontol 2014, 200:546-554.
120. Hinojosa E., Boyd A.R., Orihuela C.J. Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis 2009, 200:546-554.
121. Zhao J., Zhao J., Legge K., Perlman S. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest 2011, 121:4921-4930.
122. Hinojosa C.A., Mgbemena V., Van Roekel S., Austad S.N., Miller R.A., Bose S., et al. Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp Gerontol 2012, 47:958-965.
123. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047.
124. Anzai A., Anzai T., Nagai S., Maekawa Y., Naito K., Kaneko H., et al. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 2012, 125:1234-1245.
125. Dobaczewski M., Xia Y., Bujak M., Gonzalez-Quesada C., Frangogiannis N.G. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 2010, 176:2177-2187.
126. Hofmann U., Beyersdorf N., Weirather J., Podolskaya A., Bauersachs J., Ertl G., et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 2012, 125:1652-1663.
127. Frangogiannis N.G., Lindsey M.L., Michael L.H., Youker K.A., Bressler R.B., Mendoza L.H., et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998, 98:699-710.
128. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (New York, NY) 2009, 325:612-616.
129. Troidl C., Mollmann H., Nef H., Masseli F., Voss S., Szardien S., et al. Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J Cell Mol Med 2009, 13:3485-3496.
130. Leuschner F., Rauch P.J., Ueno T., Gorbatov R., Marinelli B., Lee W.W., et al. J Exp Med 2012, 209:123-137.
131. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007, 87:1285-1342.
132. van Amerongen M.J., Harmsen M.C., van Rooijen N., Petersen A.H., van Luyn M.J. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007, 170:818-829.
133. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002, 53:31-47.
134. Roberts R., DeMello V., Sobel B.E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976, 53:I204-I206.
135. Harel-Adar T., Ben Mordechai T., Amsalem Y., Feinberg M.S., Leor J., Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA 2011, 108:1827-1832.
136. Bujak M., Kweon H.J., Chatila K., Li N., Taffet G., Frangogiannis N.G. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol 2008, 51:1384-1392.
137. Nahrendorf M., Swirski F.K. Monocyte and macrophage heterogeneity in the heart. Circ Res 2013, 112:1624-1633.
138. Carlin L.M., Stamatiades E.G., Auffray C., Hanna R.N., Glover L., Vizcay-Barrena G., et al. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 2013, 153:362-375.
139. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science (New York, NY) 2010, 327:656-661.
140. Francis G.S. Neurohormonal control of heart failure. Cleveland Clin J Med 2011, 78(Suppl 1):S75-S79.
141. Assmus B., Iwasaki M., Schachinger V., Roexe T., Koyanagi M., Iekushi K., et al. Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur Heart J 2012, 33:1911-1919.
142. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbins C.S., et al. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.
143. Kaikita K., Hayasaki T., Okuma T., Kuziel W.A., Ogawa H., Takeya M. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol 2004, 165:439-447.
144. Tsujioka H., Imanishi T., Ikejima H., Kuroi A., Takarada S., Tanimoto T., et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009, 54:130-138.
145. Engstrom G., Melander O., Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail 2009, 2:217-222.
146. Maekawa Y., Anzai T., Yoshikawa T., Asakura Y., Takahashi T., Ishikawa S., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002, 39:241-246.
147. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105:199-206.
148. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-e151.
149. Swirski F.K., Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (New York, NY) 2013, 339:161-166.